Authors: Fontanesi, J De Guire, M Holcomb, K Sawyer, MH

Citation: J. Fontanesi et al., The cost of immunize during well-child visits, AM J MED QU, 16(6), 2001, pp. 196-201

Authors: Videtic, GMM Gaspar, LE Zamorano, L Stitt, LW Fontanesi, J Levin, KJ

Citation: Gmm. Videtic et al., Implant volume as a prognostic variable in brachytherapy decision-making for malignant gliomas stratified by the RTOG recursive partitioning analysis, INT J RAD O, 51(4), 2001, pp. 963-968

Authors: Jadhav, M Langenburg, S Fontanesi, J Slovis, TL Taub, JW

Citation: M. Jadhav et al., Hepatoblastoma with spinal metastases, J PED H ONC, 22(6), 2000, pp. 524-526

Authors: Videtic, GMM Gaspar, LE Zamorano, L Fontanesi, J Levin, KJ Kupsky, WJ Tekyi-Mensah, S

Citation: Gmm. Videtic et al., Use of the RTOG recursive partitioning analysis to validate the benefit ofiodine-125 implants in the primary treatment of malignant gliomas, INT J RAD O, 45(3), 1999, pp. 687-692

Authors: Mandell, LR Kadota, R Freeman, C Douglass, EC Fontanesi, J Cohen, ME Kovnar, E Burger, P Sanford, RA Kepner, J Friedman, H Kun, LE

Citation: Lr. Mandell et al., There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: Results ofa pediatric oncology group phase III trial comparing conventional vs. hyperfractionated radiotherapy, INT J RAD O, 43(5), 1999, pp. 959-964

Authors: Gaspar, LE Zamorano, LJ Shamsa, F Fontanesi, J Ezzell, GE Yakar, DA

Citation: Le. Gaspar et al., Permanent (125)iodine implants for recurrent malignant gliomas, INT J RAD O, 43(5), 1999, pp. 977-982